Publications
Representative Publications from over 190 Peer-Reviewed Publications by Lab Members:
*Lab trainee (graduate or undergraduate student or postdoctoral fellow)
Xie, S.X., Wang, C.Y., Prentice, R.L.: A risk set calibration method for failure time regression by using a covariate reliability sample. Journal of the Royal Statistical Society, Series B 63(4): 855-870, 2001.
Xie, S.X., Liao, D., Chinchilli, V.M.: Measurement error reduction using weighted average method for repeated measurements from heterogeneous instruments. Environmetrics 12(8): 785-790, 2001.
Clark, C.M., Xie, S., Chittams, J., Ewbank, D., Peskind, E., Galasko, D., Morris, J.C., McKeel, D.W. Jr., Farlow, M., Weitlauf, S.L., Quinn, J., Kaye, J., Knopman, D., Arai, H., Doody, R.S., DeCarli, C., Leight, S., Lee, V.M.-Y., Trojanowski, J.Q.: Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy confirmed dementia diagnoses? Archives of Neurology 60(12): 1696-1702, 2003.
Brown, G.K., Ten Have, T., Henriques, G.R., Xie, S.X., Hollander, J.E., Beck, A.T.: Cognitive therapy for the prevention of suicide attempts: A randomized controlled trial. Journal of the American Medical Association 294(5): 563-570, 2005.
Zhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E.B., Xie, S.X., Joyce, S., Li, C., Toleikis, P.M., Lee, V.M.-Y., Trojanowski, J.Q.: Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proceedings of the National Academy of Science 102(1): 227-231, 2005.
Xie, S.X., Forman, M.S., Farmer J., Moore, P., Wang, Y., Wang, X, Clark, C.M., Coslett, H.B., Chatterjee, A., Arnold, S.E., Rosen, H., Karlawish, J.H., Van Deerlin, V.M., Lee, V.M.-Y., Trojanowski, J.Q., Grossman, M.: Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery & Psychiatry 79(2): 126-129, 2008.
Grossman, M., Xie, S.X., Libon, D.J., Wang, X., Massimo, L., Moore, P., Vesely, L., Berkowitz, R., Chatterjee, A., Coslett, H.B., Hurtig, H.I., Forman, M.S., Lee, V.M.-Y., Trojanowski, J.Q. : Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology 70(22): 2036-2045, 2008.
Xie, S.X., Ewbank, D.C., Chittams, J., Karlawish, J.H.T., Arnold, S.E., Clark, C.M. : Rate of decline in Alzheimer disease measured by a dementia severity rating scale. Alzheimer Disease & Associated Disorders 23(3): 268-274, 2009.
Xie, S.X., Libon, D.J., Wang, X., Massimo, L., Moore, P., Vesely, L., Khan, A, Chatterjee, A., Coslett, H.B., Hurtig, H.I., Liang, T.-W., Grossman, M.: Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease. Journal of the International Neuropsychological Society 16(2): 278-286, 2010.
Siderowf, A., Xie, S.X., Hurtig, H., Weintraub, D., Duda, J., Chen-Plotkin, A., Shaw, L.M., Van Deerlin, V., Trojanowski, J.Q., Clark, C.: CSF Amyloid Beta 1-42 predicts cognitive decline in Parkinson's disease. Neurology 75(12): 1055-1061, 2010.
Xie, S.X., Baek, Y., Grossman, M., Arnold, S.E., Karlawish, J., Siderowf, A., Hurtig, H., Elman, L., McCluskey, L., Van Deerlin, V., Lee, V.M.-Y., Trojanowski, J.Q.: Building an integrated neurodegenerative disease database at an academic health center. Alzheimer’s & Dementia 7(4): e84-e93, 2011.
Mao, J.J., Palmer, S.C., Desai, K., Li, S.Q., Armstrong, K., Xie, S.X.: Development and validation of an instrument for measuring attitudes and beliefs about Complementary and Alternative Medicine (CAM) use among cancer patients. Evidence-Based Complementary and Alternative Medicine 2012: 798098, 2012.
*Tan, K., Libon, D.J., Rascovsky, K., Grossman, M., Xie, S.X.: Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer's Disease. Alzheimer Disease & Associated Disorders 27(4): 310-5, 2013.
*White, M.T., Xie, S.X.: Adjustment for measurement error in evaluating diagnostic biomarkers by using an internal reliability sample. Statistics in Medicine 32(27): 4709-25, 2013 Notes: This work earned Dr. White the 2011 Young Investigator Award from Statistics in Epidemiology Section of American Statistical Association and 2012 ENAR Distinguished Student Paper Award.
Toledo, J.B., Xie, S.X.#, Trojanowski, J.Q., Shaw, L.M.; for the Alzheimer's Disease Neuroimaging Initiative: Longitudinal change in CSF Tau and Abeta biomarkers for up to 48 months in ADNI. Acta Neuropathologica 126(5): 659-70, 2013 Notes: #Dr. Xie is a co-first author.
Papay, K., Xie, S.X., Stern, M., Hurtig, H., Siderowf, A., Duda, J.E., Minger, J., Weintraub, D.: Naltrexone for impulse control disorders in Parkinson’s disease: a placebo-controlled study. Neurology 83(9): 826-33, 2014.
Mao, J.J., Farrar, J.T., Bruner, D., *Zee, J., Bowman, M., Seluzicki, C., DeMichele, A., Xie, S.X.: Electro-acupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: A randomized trial. Cancer 120(23): 3744-51, 2014.
*Zee, J., Xie, S.X.: Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample. Biometrics 71(3): 772-81, 2015 Notes: This paper earned Dr. J. Zee a 2014 Student Travel Award from the Biometrics Section of the American Statistical Association.
*Zee, J., Xie, S.X.; for the Alzheimer's Disease Neuroimaging Initiative: Assessing treatment effects with surrogate survival outcomes using an internal validation subsample. Clinical Trials 12(4): 333-41, 2015.
*White, M.T., Shaw, L.M., Xie, S.X.: Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease. Journal of Alzheimer's Disease 51(2): 463-70, 2016.
*Zee, J., Xie, S.X.: The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts. Biostatistics & Epidemiology 2(1): 23-33, 2018.
*Rennert, L., Xie, S.X.: Cox regression model with doubly truncated data. Biometrics 74(2): 725-733, Jun 2018 Notes: This paper earned Dr. Rennert the W. Edwards Deming Student Scholar Award from the 2017 Annual Deming Conference on Applied Statistics.
*Rennert, L., Xie, S.X.: Bias induced by ignoring double truncation inherent in autopsy-confirmed survival studies of neurodegenerative diseases. Statistics in Medicine 38(19): 3599-3613, Aug 2019.
*Caswell, C., McMillan, C.T., Xie, S.X., Van Deerlin, V.M., Suh, E., Lee, E.B., Trojanowski, J.Q., Lee, V.M., Irwin, D.J., Grossman, M. and Massimo, L.M.: Genetic predictors of survival in behavioral variant frontotemporal degeneration. Neurology 93(18): e1707-e1714, 2019.
Giannini, L.A.A., Xie, S.X.#, Peterson, C., Zhou, C., Lee, E.B., Wolk, D.A., Grossman, M., Trojanowski, J.Q., McMillan, C.T., Irwin, D.J.: Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration. Front Neurosci 13: 682, Jul 2019 Notes: #Dr. Xie is a co-senior/co-corresponding author.
*Zhang, P., Wang, T. and Xie, S. X.: Meta analysis of several epidemic characteristics of COVID-19. Journal of Data Science 18(3): 536--549, 2020.
Robinson, J. L., Porta, S., Garrett, F. G., *Zhang, P., Xie, S. X., Suh, E., Van Deerlin, V. M., Abner, E. L., Jicha, G. A., Barber, J. M., Lee, V. M.-Y., Lee, E. B. and Nelson, P. T.: Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain 143(49): 2844—2857, 2020.
*Rennert, L., Xie, S.X..: Cox regression model under dependent truncation. Biometrics 2021 (in press).
Robinson, J. L., *Richardson, H., Xie, S. X., Suh, E., Van Deerlin, V. M., Alfaro, B., Loh, N., Porras-Paniagua, M., Nirschl, J. J., Wolk, D., Lee, V. M.-Y., Lee, E. B. and Trojanowski, J. Q.: The development and convergence of co-pathologies in Alzheimer's disease. Brain 144(3): 953—962, 2021.
*Weinshel S, Irwin DJ, Zhang P, Weintraub D, Shaw LM, Siderowf A, Xie SX.: Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer's Disease to Parkinson's Disease. J Parkinsons Dis 12(4):1155-1167, 2022.